Key Takeaways
- HPPC drove the year, but Q4 margin mix disappointed: HPPC grew 18% YoY and now contributes 75% of revenue, yet Q4 gross margin fell 2% on product mix, price moderation, and the absence of a high-margin government tender that had boosted Q3.
- Gross margin reset is structural, not cyclical: Management confirmed the new normal is ~30%, down from 37-38% at IPO, because the product basket has permanently changed through acquisitions and the loss of a single large high-margin account.
- Working capital ballooned to 97 days: A deliberate March inventory build for Agro season and a supplier shutdown, plus stretched receivables in Agro and government businesses, pushed consolidated working capital well above the standalone 67-70 day level.
- Acquisitions are outperforming payback plans: Unitop and Tristar have grown at 20% and 24% CAGR respectively over three years and will repay earlier than internally targeted, even as Unitop's Agro/Non-Agro mix shifted from 65/35 to 50/50.
- What to watch next quarter: Whether the Dahej expansion commissions on schedule by late Q2/Q3, whether Institutional Cleaning can sustain its doubling trajectory, and whether Agro volumes hold at FY24 levels as the order book currently suggests.
The Gross Margin Reset
- Q4 decline mechanics: Gross margin dropped 2% sequentially because of three simultaneous headwinds: a shift in product mix toward lower-margin lines, moderation in selling prices, and the complete absence of high-margin government tender business that had contributed Rs. 25 crore in Q3.
- Structural, not cyclical: Management was explicit that the 37-38% gross margins at IPO are not coming back. The product basket has been permanently altered by the Tristar and Unitop acquisitions, plus entry into paints, paper, and oil & gas verticals. A single large high-margin account that existed at IPO is gone and will not be replaced.
- The new baseline: The business is now expected to operate around 30% gross margin. Management's improvement strategy rests on R&D-driven cost reduction while holding or increasing selling prices, with steady raw material prices as a tailwind.
- EBITDA margin anchored lower: With the gross margin reset flowing through, management sees 13.5-14% EBITDA margin as the current base and does not expect a return to older run rates, only a gradual uptick.
Sablok: "At the time of IPO and the current scenario, the entire product basket of the company has changed significantly. We didn't have Tristar at that time. We didn't have Unitop at that time. And then we have also gone into some other verticals like paints, paper, and oil and gas. At that time, we had a big account, which you know where the margins were significantly higher, which we don't have anymore."
Working Capital: The 97-Day Question
- Standalone remains disciplined: The parent company held working capital at 67-70 days, essentially flat year-on-year. The entire deterioration is in the consolidated entity, driven by subsidiary operations.
- Four drivers of the stretch: Unitop and Tristar purchase raw materials on advance payment terms; Agro business receivables have lengthened; the Institutional Chemicals business carries an 85-90 day cycle structurally; and a deliberate March management decision built over Rs. 90 crore of inventory for the upcoming Agro season and to pre-empt a key supplier's planned April shutdown.
- Ethylene Oxide supply risk managed: Reliance has forecast supplying only 60% of normal volumes for April-May, so management built stocks in March to mitigate the shortfall. Reliance has also assured an expansion is coming to support Rossari's increased capacity, expected in the last quarter of this financial year.
- Target is sub-85 days, but prudence prevails: Management's endeavor is to bring consolidated working capital below 85 days, but it is currently prudent to assume a 90-day cycle given the structural lengthening in several business lines.
Chari: "For April and May, Reliance has given us forecast that they will be giving us about 60% of what we normally buy. So, April - May, of course, our capacity will be unutilized to that extent."
HPPC: The Engine and Its Fuel
- Scale and growth: HPPC contributed 73% of Q4 revenue and 75% of full-year revenue, growing 18% YoY. Management expects it to remain the growth driver for the next few years.
- Institutional Cleaning doubled: This sub-segment doubled turnover in FY24, serving airports, railways, hotels, and healthcare. Success is attributed to deep cleaning-chemistry expertise and tailored solutions. The organization was restructured with a new head and a rebuilt team.
- The doubling ambition carries a cash cost: Management targets doubling Institutional Cleaning again in FY25, and again the year after, aiming for Rs. 800 crore-plus where actual returns become visible. But the business is cash-consuming in both cost and working capital terms until it reaches scale, a drag management says it is willingly accepting.
- Unitop's mix shift is a hedge: In FY24, despite a poor Agro season, Non-Agro business drove Unitop's growth, shifting the mix from 65% Agro / 35% Non-Agro to roughly 50/50. New CAPEX at Unitop for surfactants, ethoxylates, and oil & gas products will support continued momentum.
- Agro volumes seen holding: Based on the current order book and incoming inquiries, management expects to maintain Agro volumes at FY24 levels, though it does not expect significant growth.
Sablok: "Our target is to double this in FY25. This business is slightly cash-consuming business in terms of cost as well as in terms of the working capital. But till it reaches a certain size and capacity, it will be a slight push on our working capital position, but that's something we are willingly doing it, because we are quite bullish that the business."
Textile and AHN: The Drags
- Textile slowdown: The Textile Speciality Chemicals division faced subdued demand and softening prices, though volumes remained steady. The drag was market-wide rather than company-specific.
- Bangladesh as the unlock: Rossari established a new office and full sales network in Bangladesh last year. Management expects to start seeing traction in another couple of months, with a good ramp-up from Q2 onwards.
- AHN missed its doubling target: Animal Health and Nutrition did not double as anticipated because the integrated feed mill industry faced margin pressure and rising outstandings. Management prudently chose not to accelerate credit into that market. The last two quarters have shown slight improvement.
- AHN recovery bet: A new premix plant and granulation facility with automated mixing technology from a multinational company is being set up, with machinery delivery and commissioning taking 4-6 months. Management expects AHN to bounce back this year, with Aqua also improving.
Exports and New Verticals
- Exports outpaced domestic: Exports grew faster than domestic markets during the year, driven by targeted customer acquisition in both new and existing geographies.
- Geographic focus: The Americas (Latin, South, North), Asia including MENA and Far East, and Europe. Product focus for the year is Home Personal Care and Agro segments, specifically Phenoxyethanol, alcohol ethoxylates, and pharma surfactants.
- Oilfield chemicals seeded: Recently commercialized, targeting Demulsifiers, Pour Point Depressants, Biocides, and Deformers. Small sales are already flowing from Unitop. This year will be mostly approval and seeding stage across Saudi Arabia, UAE, Oman, Kuwait, Qatar, Nigeria, India, and Russia, with meaningful business expected in future years.
Capacity and the FY26 Inflection
- Dahej expansion on track: Expansion projects are progressing as planned, expected to complete during FY25. CAPEX will come onstream in phases, with some capacity towards the end of Q2 or beginning of Q3. Revenue bump-up is expected by Q4, with the major bump-up in FY26.
- FY25 as a transition year: Management sees FY25 revenue as "a little similar or slightly higher" than FY24. FY26 is when the ramp-up of new capacities should drive mid to slightly higher growth.
- Next investment cycle gated: Once current CAPEX is commissioned by end of FY25, management will assess markets before committing to the next round of investments.
- Ethylene Oxide supply for expanded capacity: Reliance's planned expansion should provide adequate availability for Rossari's expanded capacity once it comes online in the last quarter of this financial year.
Sablok: "But currently, the way we look FY25, we should be a little similar or slightly higher than what we've done in the last year. But in FY26, I think the ramp-up capacities coming in, we should see mid to a slightly higher growth in FY26 and onwards."
Acquisitions: Outperforming the Deal Model
- Unitop and Tristar performance: Both have grown at 20% and 24% CAGR respectively over three years and will pay back earlier than the internal targets set at acquisition. Management stated flatly that all acquisitions have fared much better than planned.
- Unitop's mix shift as resilience: The shift from 65/35 Agro/Non-Agro to 50/50 in a poor Agro year demonstrates the portfolio's ability to flex, with Non-Agro driving growth when the core end-market softened.
- No acquisition indigestion: When asked directly whether any acquisition had underperformed, management rejected the premise, stating the financials prepared at the time of acquisition have been exceeded.
Sablok: "No. I think on the contrary all the acquisitions that we've done has fared much better than what we had planned. Whatever financials we had prepared at the time of acquisition, I think both these have really done much better than that."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Dahej expansion commissioning | CAPEX onstream in phases; revenue bump-up by Q4, major bump-up in FY26 | Some capacity by end-Q2/early-Q3 FY25; full commissioning by end-FY25 |
| Institutional Cleaning doubling | Double turnover in FY25; double again the following year | FY25 and FY26 |
| Consolidated working capital | Bring below 85 days (currently 97 days) | No date; prudent to assume 90-day cycle currently |
| AHN recovery | Bounce back with new premix plant and granulation facility | This year (FY25); machinery commissioning takes 4-6 months |
| Agro volumes | Maintain at FY24 levels based on current order book | FY25 |
| FY25 revenue | Similar or slightly higher than FY24 | FY25 |
| FY26 revenue | Mid to slightly higher growth on capacity ramp-up | FY26 |
| EBITDA margin base | 13.5-14% as the base; gradual uptick expected, not returning to older run rates | FY25 |
| Ethylene Oxide supply normalization | Reliance expansion to support Rossari's expanded capacity | Last quarter of this financial year |
Key Metrics
| Metric | Q4 FY24 |
|---|---|
| Revenue | ₹472.7 crore, +16.3% YoY |
| HPPC revenue growth | ~18% YoY |
| Revenue mix | HPPC 73%, Textile 20%, AHN 7% |
| EBITDA | ₹63.6 crore, +16.5% YoY, consistent QoQ |
| PAT | ₹34.1 crore, +17.8% YoY, steady QoQ |
| Gross margin | ~2% lower in Q4; full year steady at 29% |
| FY24 full-year revenue | ₹1,830.6 crore, +10.5% YoY |
| FY24 full-year EBITDA | ₹249.8 crore, highest annual EBITDA, margin 13.6% |
| FY24 full-year PAT | ₹130.7 crore, highest annual PAT |
| FY25 revenue milestone | ~₹2,000 crore expected top line |
| Textile volume growth | ~5% annualized in FY24; Q4 volumes up ~10% QoQ |
| Institutional Cleaning FY24 revenue | ₹159 crore, ~4% EBITDA margin |
| Institutional Cleaning working capital | 85–90 days |
| Unitop Agro/Non-Agro mix | 50%–50%, shifted from 65%–35% in FY23 |
| Standalone working capital | 69–70 days |
| Consolidated working capital | 97 days closing; target to bring to 90 days, then below 85 days |
| CAPEX planned | ₹128-odd crore for ethoxylation expansion and oil & gas molecule |
| Unitop 3-year CAGR | ~20% |
| Tristar 3-year CAGR | 24% |
| EBITDA margin outlook | 13.5%–14% |
| Ethylene Oxide supply (Apr–May) | ~60% of normal purchase volume |